Oklo Inc. Reports Q2 2025 Results: Capital Raise and Strategic Milestones Amid Widening Losses

Oklo Inc. (NYSE: OKLO) unveiled its Q2 2025 results, marked by a $440 million capital raise that bolstered liquidity to $683 million. The funding extends the company's cash runway through 2028, supporting its Aurora reactor project. However, the MOVE comes with a 50% dilution in shares since 2024, raising investor concerns about long-term valuation.

GAAP losses widened to $0.18 per share, exceeding consensus estimates. Regulatory progress included NRC readiness approval, with a COLA submission slated for Q4 2025. Strategic wins included a U.S. military power purchase agreement and the acquisition of Atomic Alchemy, alongside global partnerships.

Institutional buying remains robust, though insider sales have introduced caution. The stock closed at $71.86, down 4.59%, with pre-market trading dipping further to $70.64.